Clinical and Translational Epidemiology
The Clinical and Translational Epidemiology Branch in NCI’s Epidemiology and Genomics Research Program stimulates, promotes, and supports cancer epidemiologic research to identify clinical, genomic, and lifestyle factors that improve outcomes for cancer survivors.
We also support research that examines factors associated with cancer development among individuals with underlying diseases and conditions.
Research areas of interest include:
- cancer survivor research
- adverse events and late effects
- diet/lifestyle factors
- predictive, prognostic and genomic factors
- pharmacoepidemiology and pharmacogenomics
- clinical epidemiology and risk prediction
Learn more about CTEB’s interests in the following areas, relevant funding opportunity announcements, related EGRP events, and staff contacts.
Cancer and Accelerated Aging
NCI and the National Institute of Aging (NIA) are fostering research that characterizes aging phenotypes and identifies treatment-associated changes in aging trajectories in cancer survivors, with the ultimate goal of developing interventions to optimize health outcomes.
Cancer and Emergency Medicine
NCI and others at NIH are supporting efforts to improve cancer outcomes by mitigating unnecessary emergency department (ED) use and developing risk-based stratification and management guidelines for cancer care in the ED.
Cancer Treatment-Related Cardiotoxicity
NCI and the National Heart, Lung, and Blood Institute (NHLBI) are supporting research to understand, prevent, and manage cancer treatment-related cardiovascular dysfunction while optimizing cancer outcomes.
Staff in EGRP partner with others at NCI and NIH to foster research to better understand the causes of health disparities and develop interventions to reduce differences in the incidence, prevalence, mortality, and burden of cancer and related adverse health conditions that exist among specific population groups in the United States.
Inherited Cancer Syndromes
NCI, under the auspices of the Cancer Moonshot initiative, is supporting research to improve the current state of genetic counseling and testing, prevention, and early detection for those with at high-risk for cancer.
Cancer Epidemiology Descriptive Cohort Database
The Cancer Epidemiology Descriptive Cohort Database (CEDCD) contains information about cohort studies that follow groups of persons over time for cancer incidence, mortality, and other health outcomes.
Observational Data Collection
This report describes ways NCI’s Division of Cancer Control and Population Sciences (DCCPS) expands population-based observational data. It also provides information about data available through DCCPS and our partners.
Body Composition and Cancer Outcomes Research Webinar Series
The purpose of this new webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research on integrating measures of body composition in cancer epidemiology research.
Keep up to date about the current Clinical and Translational Epidemiology projects and initiatives ongoing at EGRP.
Patterns of Cannabis Use Among Cancer Patients
A first step in addressing research gaps regarding cannabis and cancer is to understand the patterns and extent of cannabis use among cancer patients, including those undergoing or having recently completed active treatment. NCI's Division of Cancer Control and Population Sciences provided administrative supplements to 12 NCI-designated cancer centers to conduct surveys in over 12,000 ambulatory cancer patients to better understand patterns of cannabis use among cancer patients. The research sites will survey cancer patients currently receiving treatment, or recently completed treatment and include a diverse population by age, sex, race/ethnicity, geography, and tumor type. Results are expected in early 2022.